Good
Mostly Aligned
Patient Risk:
Low
Summary
Most claims are supported by the label. One brand name (Temesta) is not present in the label, representing a minor omission.
Category Scores
Accurate Statements
Lorazepam is the generic name.
DESCRIPTION (11. DESCRIPTION)
Brand names include Ativan (US).
DESCRIPTION (11. DESCRIPTION)
Tablets are available in 0.5 mg, 1 mg, and 2 mg.
DOSAGE FORMS AND STRENGTHS (3. DOSAGE FORMS AND STRENGTHS)
Injectable solution is 2 mg/mL.
DOSAGE FORMS AND STRENGTHS (3. DOSAGE FORMS AND STRENGTHS)
Oral solution is available.
DOSAGE FORMS AND STRENGTHS (3. DOSAGE FORMS AND STRENGTHS)
Unsupported Statements
Brand names include Temesta (many other countries).
Temesta is not listed in the provided label.
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
Evaluation based solely on allowing statements about formulation and branding; no safety-related claims or risk estimates were presented.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Temesta brand name not present in the label.
Suggested Improvement
If brand names are to be listed, ensure international brands are accurately reflected or clearly stated as region-specific.